Evogene Q2 EPS $(0.32) Misses $(0.18) Estimate

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.18) by 77.78 percent. This is a 100 percent decrease over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $135.00 thousand which missed the analyst consensus estimate of $300.00 thousand by 55.00 percent. This is a 54.70 percent decrease over sales of $298.00 thousand the same period last year.